North Brunswick New Jersey based Fidelis Pharmaceuticals is raising $5,129,692.00 in New Equity Investment.
North Brunswick, NJ – According to filings with the U.S. Securities and Exchange Commission, Fidelis Pharmaceuticals is raising $5,129,692.00 in new funding. Sources indicate as part of senior management Chief Operating Officer, Barry Levinson played…